Encyclopedia

  • Fabrication of adenosine 5′-triphosphate-capped silver nanoparticles: Enhanced cytotoxicity efficacy and targeting effect against tumor cells
  • Add time:08/28/2019         Source:sciencedirect.com

    The aim of this study is to investigate the effect of different concentrations of adenosine 5′-triphosphate (ATP) as a stabilizing agent on the physicochemical and biological behavior of AgNPs. The results revealed that the size of distribution and dispersion of AgNPs were controlled by changes in the ratio of ATP and AgNO3 in the presence of NaBH4. The data of FT-IR and zeta potential values show that ATP molecules have been coordinated on the surface of nanoparticles through the adenine moiety of ATP. Cellular viability studies in osteosarcoma cells (Saos-2), breast cancer cells (MCF-7 and T47D), and leukemia cells (K562) demonstrated that ATP-capped silver nanoparticles ([email protected]) possess high antitumor efficacy compared with the naked ones. It was found that the cellular uptake of [email protected] occurs through P2X7 receptors and clathrin-mediated endocytosis. As the P2X7 receptor is overexpressed on the surface of many tumor cells; ATP on nanoparticle surface plays the role of a targeting molecule. Moreover, it was demonstrated that the cytotoxicity induced by [email protected] proceeds from the perturbation of intracellular oxidative status, leading to the induction of apoptosis. From these data, ATP, as “dispersant” and “complexant,” improves the physicochemical properties of AgNPs and potentiates their application in cancer therapy.

    We also recommend Trading Suppliers and Manufacturers of 3'(O)-(1-oxyl-2,2,5,5-tetramethyl-3-carbonyl pyrrolidine)-8-azidoadenosine 5'-triphosphate (cas 113814-58-7). Pls Click Website Link as below: cas 113814-58-7 suppliers


    Prev:Terbium ion-coordinated carbon dots for fluorescent aptasensing of adenosine 5′-triphosphate with unmodified gold nanoparticles
    Next: Solid-phase synthesis of 5′-triphosphate 2′-5′-oligoadenylates analogs with 3′-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View